此应用程序的某些内容目前无法使用。
如果这种情况持续存在,请联系我们反馈与联系
1. (WO2017153939) PHARMACEUTICAL COMPOSITION COMPRISING CANAGLIFLOZIN, PROCESS OF PREPARATION AND USE THEREOF
国际局存档的最新著录项目数据    提交意见

公布号: WO/2017/153939 国际申请号: PCT/IB2017/051377
公布日: 14.09.2017 国际申请日: 09.03.2017
国际专利分类:
A61K 9/20 (2006.01)
A 人类生活必需
61
医学或兽医学;卫生学
K
医用、牙科用或梳妆用的制剂
9
以特殊物理形状为特征的医药配制品
20
丸剂、锭剂或片剂
申请人:
BARIK, Satyabrata [IN/IN]; IN
CHOKKASANDRA JAYARAMAREDDY, Venugopala [IN/IN]; IN
MEENAKSHISUNDERAM, Sivakumaran [IN/IN]; IN
AUROBINDO PHARMA LIMITED [IN/IN]; Aurobindo Pharma Limited, The Water Mark Building, Plot No.11, Survey No.9, Kondapur, Hitech City, Hyderabad, Pin - 500 084, Telangana, Hyderabad 500 084, IN
发明人:
BARIK, Satyabrata; IN
CHOKKASANDRA JAYARAMAREDDY, Venugopala; IN
MEENAKSHISUNDERAM, Sivakumaran; IN
共同
代表:
AUROBINDO PHARMA LIMITED; IN
优先权数据:
20164100834910.03.2016IN
标题 (EN) PHARMACEUTICAL COMPOSITION COMPRISING CANAGLIFLOZIN, PROCESS OF PREPARATION AND USE THEREOF
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA CANAGLIFLOZINE, PROCÉDÉ DE PRÉPARATION ET UTILISATION DE CELLE-CI
摘要:
(EN) The present invention relates to a binder free pharmaceutical composition comprising canagliflozin or a prodrug or a pharmaceutically acceptable salt thereof, and one or more 5 pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioequivalence profile to that of INVOKANA® tablets.
(FR) La présente invention concerne une composition pharmaceutique sans liant comprenant de la canagliflozine ou un promédicament ou sel pharmaceutiquement acceptable de celle-ci, et un ou plusieurs excipients pharmaceutiquement acceptables, où ladite composition est exempte de canaglifozine hémihydratée, et présente un profil acceptable de stabilité chimique, de stabilité polymorphique et de bioéquivalence et dissolution comparative, par rapport à celui des comprimés INVOKANA®.
front page image
指定国: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
非洲地区知识产权组织 (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
欧亚专利局 (AM, AZ, BY, KG, KZ, RU, TJ, TM)
欧洲专利局 (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
非洲知识产权组织 (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
公布语言: 英语 (EN)
申请语言: 英语 (EN)